Correlation Between Edgewise Therapeutics and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Spyre Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Spyre Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Spyre Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Spyre is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Spyre Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.59 times more return on investment than Spyre Therapeutics. However, Edgewise Therapeutics is 1.69 times less risky than Spyre Therapeutics. It trades about -0.09 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.22 per unit of risk. If you would invest 3,404 in Edgewise Therapeutics on August 27, 2024 and sell it today you would lose (184.00) from holding Edgewise Therapeutics or give up 5.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Spyre Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Spyre Therapeutics |
Edgewise Therapeutics and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Spyre Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. HCW Biologics | Edgewise Therapeutics vs. Scpharmaceuticals | Edgewise Therapeutics vs. Milestone Pharmaceuticals |
| Spyre Therapeutics vs. Eliem Therapeutics | Spyre Therapeutics vs. HCW Biologics | Spyre Therapeutics vs. Scpharmaceuticals | Spyre Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |